Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Business intelligence in the global biopharmaceutical sector focuses on drug patent dynamics and the entry of generics. It is essential to forecast future budget needs and proactively seek out generic alternatives. Analyzing the achievements of past patent challengers provides insights into the competitive landscape and informs research directions. This analysis plays a crucial role in guiding portfolio management strategies for upcoming drug development projects. Additionally, anticipating the expiration of patents on branded drugs, pinpointing potential generic suppliers, and managing branded drug inventory effectively are vital. Furthermore, acquiring detailed formulation and manufacturing data helps in identifying key formulators, repackagers, and relabelers to streamline operations and enhance market positioning. Understanding these elements can significantly bolster strategic decision-making in the biopharmaceutical industry.

Description

Harnessing RNA sequencing (RNA-seq) data alongside Artificial Intelligence presents both a crucial necessity and a significant opportunity for creating therapies aimed at correcting splicing errors. By leveraging machine learning, we can uncover novel splicing errors and swiftly formulate therapeutic compounds to address them. Our AI platform, SpliceCore, is specifically designed for discovering RNA therapeutics. This cutting-edge technology focuses on analyzing RNA sequencing data with unparalleled efficiency. It can swiftly identify, evaluate, and validate potential drug targets, outpacing traditional methodologies. Central to SpliceCore is our unique repository containing over 5 million potential RNA splicing errors, making it the largest of its kind globally and instrumental for testing any RNA sequencing dataset submitted for analysis. The integration of scalable cloud computing allows us to handle vast quantities of RNA sequencing data in a way that is not only efficient but also cost-effective, significantly speeding up the pace of therapeutic advancements. This innovative approach promises to revolutionize the landscape of RNA therapeutics.

API Access

Has API No 

API Access

Has API No 

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

$250 per month
Free Trial No 
Free Version Yes 

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Customer Support

Business Hours Yes 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs No 
Webinars No 
Live Training (Online) No 
In Person No 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) No 
In Person Yes 

Vendor Details

Company Name

DrugPatentWatch

Founded

2003

Country

United States

Website

www.drugpatentwatch.com

Vendor Details

Company Name

Envisagenics

Founded

2014

Country

United States

Website

www.envisagenics.com/platform/

Product Features

Product Features

Alternatives

Healnet Reviews

Healnet

Healx

Alternatives

Splice Reviews

Splice

Bending Spoons
MapItRight Reviews

MapItRight

Custom Software, Inc.
BIOiSIM Reviews

BIOiSIM

VERISIMLife
SPLICE Dialog Suite Reviews

SPLICE Dialog Suite

SPLICE Software
Zapdex Reviews

Zapdex

Product Research, Inc.